ArticleTherapeutic advances in medical oncology2026

Adebrelimab-based regimens as first-line treatment for ES-SCLC in specific populations: a real-world study in Chinese patients.

Liyang Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.